Oxidized low density lipoprotein (Human) (Synonyms:Human ox-LDL)
目录号 : KM32324 纯度 : 98%

Human oxidized low density lipoprotein (ox-LDL) 是一种关键的促动脉粥样硬化信号调节剂和凋亡诱导剂。它通过结合 TLR4 及 SR-A、CD36、LOX-1 等清道夫受体介导细胞摄取与信号传导,并定位于动脉粥样硬化病变部位。在凋亡调控方面,ox-LDL 通过配体依赖性的 Fas 受体通路及共激活的 TNF 受体 I/II 介导凋亡活性,诱导 Caspase 2、3、6、8 活性亚基形成,同时上调促凋亡蛋白 Bad、下调抗凋亡蛋白 Bcl-2,发挥细胞毒性作用。此外,ox-LDL 还可激活 MAPK、NFκB、p53 及 AP-1 等多种信号通路,诱导泡沫细胞形成和单核细胞趋化,刺激血管细胞增殖、细胞因子产生及血小板活化,同时抑制内皮依赖性血管舒张。该分子可用于动脉粥样硬化的相关研究。

规格 价格 是否有货 数量
1mg
In-stock
2mg
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

Oxidized low density lipoprotein (Human) (Human ox-LDL) is a key pro-atherosclerotic signal regulator and apoptosis inducer. Oxidized low density lipoprotein (Human) mediates cellular uptake and signal transduction by binding to TLR4 and scavenger receptors such as SR-A, CD36, LOX-1, and localizes to atherosclerotic lesion sites. Oxidized low density lipoprotein (Human) mediates Apoptosis activity through the ligand-dependent Fas receptor pathway and co-activated TNF receptors I/II, induces the formation of active subunits of Caspase 2, 3, 6, 8, and simultaneously activates multiple signaling pathways including MAPK, NFκB, p53 and AP-1 complexes. Oxidized low density lipoprotein (Human) exerts cytotoxicity by upregulating the pro-apoptotic protein Bad and downregulating the level of the anti-apoptotic protein Bcl-2, inducing foam cell formation and monocyte chemotaxis. Oxidized low density lipoprotein (Human) also stimulates vascular cell proliferation, cytokine production and platelet activation, while inhibiting endothelium-dependent vasodilation. Oxidized low density lipoprotein (Human) can be used in atherosclerosis-related research.

体外研究

Oxidized low density lipoprotein (Human) (200 μg/mL; 24 h) 可激活Caspase 2、3、6、8;

Oxidized low density lipoprotein (Human) (200 μg/mL; 24 h) 可激活NF-κB、AP-1;升高p53、ATF-2、ELK-1、CREB.

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Store at 2-8°C for 20 weeks, avoid freeze.
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度 mg/ml;

DMSO母液配制方法 mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。